Current Infectious Disease Reports

, Volume 15, Issue 4, pp 295–298

Middle East Respiratory Syndrome coronavirus (MERS CoV): Update 2013

Invited Commentary

DOI: 10.1007/s11908-013-0344-2

Cite this article as:
Lim, P.L., Lee, T.H. & Rowe, E.K. Curr Infect Dis Rep (2013) 15: 295. doi:10.1007/s11908-013-0344-2

Abstract

Middle East Respiratory Syndrome coronavirus (MERS CoV) came to attention as an emerging pathogen causing severe respiratory illness in patients from the Middle East in September 2012. As of 14 June 2013, 58 human cases of MERS CoV infection have been confirmed, including 33 deaths (case fatality rate of 57%). MERS CoV is a beta-coronavirus, in the same family as SARS-CoV, and shares a probable origin from bats. No animal reservoir or intermediates have been definitely implicated in transmission. Limited human-to-human transmission has occurred within several clusters, as individuals without a recent travel history have become infected after exposure to an ill returned traveler.

Keywords

Middle East Respiratory Syndrome coronavirus (MERS CoV) Coronavirus Respiratory illness SARS 

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of Infectious Disease, Institute of Infectious Disease and EpidemiologyTan Tock Seng HospitalSingaporeSingapore
  2. 2.Lee Kong Chian School of MedicineNanyang Technological UniversitySingaporeSingapore

Personalised recommendations